- Home
- PODC vs CCEL Comparison
PODC vs CCEL Comparison
Compare PODC & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- CCEL
- Stock Information
- Founded
- PODC 2013
- CCEL 1989
- Country
- PODC United States
- CCEL United States
- Employees
- PODC N/A
- CCEL N/A
- Industry
- PODC
- CCEL Managed Health Care
- Sector
- PODC
- CCEL Health Care
- Exchange
- PODC Nasdaq
- CCEL Nasdaq
- Market Cap
- PODC 44.1M
- CCEL 39.9M
- IPO Year
- PODC N/A
- CCEL 1997
- Fundamental
- Price
- PODC $2.40
- CCEL $5.19
- Analyst Decision
- PODC
- CCEL Strong Buy
- Analyst Count
- PODC 0
- CCEL 1
- Target Price
- PODC N/A
- CCEL $8.50
- AVG Volume (30 Days)
- PODC 86.3K
- CCEL 14.7K
- Earning Date
- PODC 06-18-2025
- CCEL 07-14-2025
- Dividend Yield
- PODC N/A
- CCEL 19.49%
- EPS Growth
- PODC N/A
- CCEL N/A
- EPS
- PODC N/A
- CCEL 0.01
- Revenue
- PODC $52,119,000.00
- CCEL $32,102,750.00
- Revenue This Year
- PODC $19.39
- CCEL $2.49
- Revenue Next Year
- PODC $23.41
- CCEL $0.95
- P/E Ratio
- PODC N/A
- CCEL $568.17
- Revenue Growth
- PODC 20.36
- CCEL 2.33
- 52 Week Low
- PODC $1.10
- CCEL $4.75
- 52 Week High
- PODC $2.85
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- PODC 68.42
- CCEL 51.22
- Support Level
- PODC $1.83
- CCEL $5.00
- Resistance Level
- PODC $2.75
- CCEL $6.35
- Average True Range (ATR)
- PODC 0.25
- CCEL 0.31
- MACD
- PODC 0.06
- CCEL 0.02
- Stochastic Oscillator
- PODC 80.00
- CCEL 14.07
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.